C
Clinical Need
How urgent, specific, and underserved the clinical problem is, including patient burden, diagnostic or treatment gaps, workflow pain, and whether the proposed use case maps to a real decision point in care.
CORTEX framework
The CORTEX Signal Framework
A clinician-led framework for evaluating emerging neurotechnology before hype outruns evidence, ethics, and clinical meaning.
What it evaluates
Six dimensions for separating meaningful signal from market noise.
CORTEX is a structured interpretation framework used by Cortex Signals to assess whether an emerging neurotechnology is clinically relevant, commercially plausible, ethically responsible, and ready for deeper attention. It is designed for public analysis and strategic diligence—not automated investment advice, medical advice, or a database product.
Dimensions
Each domain is scored from 0 to 5.
O
Outcome Evidence
The strength of the evidence behind the signal: study design, clinically meaningful endpoints, reproducibility, effect size, comparator quality, longitudinal durability, and relevance to real-world populations.
R
Regulatory & Reimbursement Path
The clarity of the approval, coverage, coding, and payment route. Higher scores reflect realistic regulatory strategy, credible reimbursement assumptions, and a buyer pathway that matches the intended clinical use.
T
Technology Defensibility
The durability of the technical advantage, including data assets, model performance, hardware or sensor differentiation, intellectual property, integration depth, and how difficult the signal is to replicate.
E
Ethics & Neural Data Risk
The maturity of the approach to privacy, consent, explainability, bias, patient autonomy, vulnerable populations, and the special sensitivity of neural, behavioral, and cognitive data.
X
Execution & Capital Signal
Whether the team, partnerships, financing, commercial traction, and operating discipline support the next stage of adoption without overreaching beyond the evidence or market readiness.
Scoring system
A 0–30 score that keeps evidence, risk, and execution in the same conversation.
Each dimension receives a score from 0 to 5, then the six scores are summed for a total CORTEX Signal Score. A high score does not mean a technology is guaranteed to succeed. It means the available signal is stronger, more coherent, and more clinically interpretable across the dimensions that matter.
030
Score bands
Interpreting the CORTEX Signal Score.
Weak or premature signal
The concept may be interesting, but the clinical case, evidence base, path to market, or operating signal is too thin for confident interpretation.
Watchlist signal
There is enough substance to monitor, but important gaps remain before the technology can be treated as clinically or commercially persuasive.
Promising signal
The technology shows credible alignment between clinical need, evidence, market path, and execution, while still requiring focused diligence on remaining risks.
High-conviction signal
The signal is unusually strong across the framework and suggests a technology with meaningful clinical relevance, defensibility, and adoption potential.
How Cortex uses the framework
One framework, three levels of interpretation.
Cortex Signals
Public articles and newsletter issues will use the framework through selected signal language, clinical interpretation, and occasional scores when a score adds clarity.
Cortex Capital Intelligence
The future capital intelligence layer will apply the framework more formally through paid scored signal briefs, watchlists, diligence questions, and trend intelligence.
Cortex Insights
Custom reports, advisory work, educational briefings, and strategic analysis will use the framework to translate neurotechnology developments into practical clinical-commercial context.
Clinician-led interpretation
Why clinical judgment matters.
Neurotechnology signals are often framed around technical novelty, funding momentum, or headline outcomes. Clinician-led interpretation asks a different set of questions: Does this solve a real care problem? Would it change a diagnosis, treatment decision, monitoring plan, or patient experience? Can it fit into clinical workflows without adding unmanageable risk or burden?
The CORTEX framework keeps patient relevance, evidence quality, implementation reality, and neural data ethics at the center of evaluation. That clinical lens helps founders, investors, and operators understand not only whether a technology is exciting, but whether it is likely to become useful.
Developed in public
The CORTEX Signal Framework is being developed in public. Its language, scoring discipline, and use cases will become more refined as Cortex Signals grows and the evidence base around emerging neurotechnology continues to mature.